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Abstract—Cells inside a 3D matrix (such as tissue extracel-
lular matrix or biomaterials) sense their insoluble environ-
ment through speciﬁc binding interactions between their
adhesion receptors and ligands present on the matrix surface.
Despite the critical role of the insoluble matrix in cell
regulation, there exist no widely-applicable methods for
quantifying the chemical stimuli provided by a matrix to
cells. Here, we describe a general-purpose technique for
quantifying in situ the density of ligands for speciﬁc cell
adhesion receptors of interest on the surface of a 3D matrix.
This paper improves signiﬁcantly the accuracy of the
procedure introduced in a previous publication by detailed
marker characterization, optimized staining, and improved
data interpretation. The optimized methodology is utilized to
quantify the ligands of integrins a1b1, a2b1 on two kinds of
matched porous collagen scaffolds, which are shown to
possess signiﬁcantly different ligand density, and signiﬁcantly
different ability to induce peripheral nerve regeneration
in vivo. Data support the hypothesis that cell adhesion
regulates contractile cell phenotypes, recently shown to be
inversely related to organ regeneration. The technique
provides a standardized way to quantify the surface chem-
istry of 3D matrices, and a means for introducing matrix
effects in quantitative biological models.
Keywords—Adhesion, Biomaterials, Collagen, Extracellular
matrix, Integrin, Nerve regeneration, Surface chemistry.
INTRODUCTION
Cells in vivo interact extensively with 3D matrices,
such as the native extracellular matrix (ECM) of tis-
sues or implanted biomaterials. Cells sense and re-
spond to their insoluble microenvironment through
speciﬁc binding interactions between their adhesion
receptors and ligands present on the matrix surface.
The effects of such cell–matrix interactions have been
shown to affect strongly key cell phenotypes. Examples
include the role of ECM in tumor progression,2,23 and
the ability of certain biomaterials to induce regenera-
tion,33 or control stem cell fate.15
A prerequisite for cell–matrix interactions is the
presence of appropriate ligands for cell adhesion
receptors on the matrix. Many studies have focused on
the identity of adhesion ligands present on ECM bio-
molecules, particularly ligands for integrins, the major
family of adhesion receptors.16 In particular, it has
been shown that cells bind to collagen type I (the major
ECM component of many tissues) mainly via collagen-
binding integrins, which recognize several ligands on
the collagen molecule6,29. Although there is signiﬁcant
progress in characterizing elementary binding interac-
tions of adhesion receptors to their ligands on ECM
molecules,24 the chemical environment sensed by cells
inside tissue stroma or biomaterial grafts has been not
been studied in detail yet.
The surface chemistry of a matrix (deﬁned here as
the density of ligands for particular adhesion receptors
available to cells) determines which adhesion receptors
can be utilized by cells, controls the perception of the
cell about its insoluble environment, and induces
intracellular signaling.25 Despite its importance, the
vast majority of published studies on cell–matrix
interactions do not report the surface chemistry of the
utilized matrix. Few studies report instead the mass of
Address correspondence to Dimitrios S. Tzeranis, Department of
Mechanical Engineering, National Technical University of Athens,
15780 Zografou, Greece. Electronic mail: tzeranis@gmail.com,
tzeranis@mail.ntua.gr
Annals of Biomedical Engineering, Vol. 44, No. 3, March 2016 ( 2015) pp. 803–815
DOI: 10.1007/s10439-015-1445-x
0090-6964/16/0300-0803/0  2015 Biomedical Engineering Society
803
adsorbed matrix biomolecules on cell culture
dishes,10,22,31 a measurement not necessary analogous
to its surface chemistry. A key reason for this omission
is the lack of appropriate methods for quantifying the
surface chemistry of the insoluble microenvironment
of cells. The few available methods are often non-
quantitative, and not widely-applicable, since they can
be applied only in RGD-functionalized synthetic bio-
materials.3,12,19 Some spectroscopic techniques can
quantify chemical groups on the surface of biomate-
rials,18,20 however these measurements cannot be con-
verted straightforwardly into density of ligands of
particular adhesion receptors.
This study describes in detail a technique for
quantifying the density of ligands of a particular
adhesion receptor on the surface of a 3D matrix in situ.
It improves signiﬁcantly the accuracy of the concept
introduced in a previous publication30 in three ways:
(1) detailed characterization of ﬂuorescent analogs of
the two major collagen-binding integrins (a1b1, a2b1),
(2) optimized marker staining protocols that increase
sensitivity and minimize background staining, (3)
estimation of ligand density via a binding model that
considers the nature of soluble marker to an 3D ma-
trix. The methodology is utilized to quantify the li-
gands of integrins a1b1, a2b1 on two matched porous
collagen scaffolds, similar to grafts used clinically in
induced peripheral nerve regeneration. The effects of
biomaterial surface chemistry were investigated by
imaging ex vivo sections of transected peripheral nerves
treated with the two scaffolds and focusing on the ef-
fects of surface chemistry on cell-scaffold adhesion and
wound contraction, a phenotype proposed to affect
critically the ﬁnal wound healing outcome.33
MATERIALS AND METHODS
Scaﬀold Fabrication
Sheets of porous collagen scaﬀolds were fabricated
by freeze-drying a 0.5% w/v micro-ﬁbrilar collagen I
suspension using published protocols.27 The dry out-
come of freeze-drying (scaffold A) is cross-linked by
either dehydro-thermal treatment (DHT) at 120 C for
48 h at 50 mTorr (scaffold D) or chemically via treat-
ment with 14.4 mM EDC and 5.6 mM NHS for 1 h at
room temperature (scaffold E), Fig. 1a.
Expression and Puriﬁcation of I Domains
Soluble ﬂuorescent analogs of the two major colla-
gen-binding integrins (a1b1, a2b1) were prepared by
fusing the tetracysteine (TC) tag WDCCPGCCK at
the N-terminus of the I domains of the a subunit of the
corresponding integrin by PCR.1 GST-I domain fusion
proteins were expressed in BL21 e-coli, puriﬁed via
afﬁnity chromatography, and treated with thrombin to
remove the GST domain following published proto-
cols.6,29 I domain solutions were carefully concentrated
via ﬁlter centrifugation in assay buffer (PBS,
2 mM MgCl2, 2 mM TCEP, 0.02% tween20), stored
at 4C, and used within 20 days. The concentration
and purity of puriﬁed I domain solutions was evalu-
ated via 280 nm absorption and SDS-PAGE.
Circular Dichroism Spectroscopy
The contribution of secondary structures in puriﬁed
I domain solutions was estimated by circular dichroism
spectroscopy in an Aviv Model 202 CD spectrometer
(Aviv Biomedical) using a far-UV quartz cuvette (New
Era enterprises Inc). I domain solutions were diluted in
assay buffer so that their 280 nm absorption was
approximately 0.17. The measured ellipticity h(k) was
buffer corrected and converted into mean residue
ellipticity hmrw kð Þ. Secondary structure contribution
was estimated by three soft ware tools (SELCON3,
CONTINLL, CDSSTR, Colorado State University).
For tag-free I domains secondary structure predictions
were compared with secondary structures annotated in
X-ray structures 1QCY and 1AOX.
Surface Plasmon Resonance
The binding of puriﬁed recombinant I domains to
collagen I or gelatin was evaluated via the surface
plasmon resonance (SPR) assay in a BIACORE T100
(GE Healthcare Bio-Sciences AB) following previously
published protocols.6 1200 RU of ligands (30 lg/ml
collagen I from tail tendon (BD biosciences) or gelatin
(collagen I denatured by heating at 65 C for 30¢) in
10 mM sodium acetate pH 4.5 were immobilized on
the surface of CM5 chips (GE Healthcare): collagen I
in chambers 2 and 4, gelatin in chamber 3, no ligand in
chamber 1. The binding of each analyte to its immo-
bilized ligands was studied by ﬂowing 40 lL/min
solutions of increasing analyte concentration (0.05 to
6 lM in HBS-P + supplemented with 1 mM MgCl2)
for 3 min, followed by dissociation in 40 lL/min run-
ning buffer for 12 min, and regeneration by 20 lL/min
regeneration buffer (HBS-P+, 10 mM EDTA, 0.01%
v/v SDS) for 1 min. Each condition was performed in
duplicates. Raw sensorgrams were processed either by
custom-written software (Supplementary Material) or
by the BiaEval software (GE Healthcare). Data pro-
cessing includes compensation of various artifacts, and
global ﬁtting of corrected sensorgrams into a 1:1
binding model that describes the kinetics of the de-
tected SPR signal R tð Þ:
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FIGURE 1. Structure of porous collagen scaffolds probed in this study. (a) Schematic of scaffold fabrication flow-chart high-
lighting differences in the chemistry of the two methods utilized for scaffold cross-linking. (b) SEM image of a collagen scaffold
highlighting its porous structure and the dimensions of its struts (Image acquired by A. Kourgiantaki, University of Crete). (c) High
magnification TEM image of a scaffold strut demonstrating D-banding in microfibrillar collagen (asterisks).
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dR
dt
þ kon  I0 þ koffð Þ  R ¼ kon  I0  Rmax
where kon and koff are the association and dissociation
rates of the analyte-ligand binding reaction, I0 is ana-
lyte concentration, MI and MC are the MW of I do-
main and collagen respectively, and Rmax is the
maximum steady state signal achieved when all ligands
per collagen molecule are bound to analyte.
Ligand Density Assay
Ligand density measurements took place in cylin-
drical scaﬀold samples (2 mmdiameter, 3 mmheight) in
PCR tubes. Scaﬀold samples were hydrated in PBS,
blocked with 100 lL superblock in PBS (Thermo sci-
entiﬁc) for 3 h at 4 C, treated with stained TC-tagged I
domain solutions (sometimes supplemented with non-
tagged I domains) overnight at 4 C, and imaged in a
multi-photon microscope (Fig. 3a). Each binding assay
consists of two distinct experiments. In ‘‘binding’’
experiments, I domain buffer is supplemented with
2 mM MgCl2. In ‘‘control’’ experiments, I domain
buffer is supplemented with 10 mM EDTA. TC-tagged
I domain staining is done by treatment with 1 mM
TCEP for 2 h at 4 C and then with 5% excess FlAsH-
EDT2 in the presence of 1 mM bme and 1 mM TCEP
for 3 h at 4 C. Careful removal of unbound FlAsH
from FlAsH-stained I domains via gel ﬁltration (micro
bio-spin 6, Biorad Laboratories Inc.) prevents non-
speciﬁc binding of FlAsH to blocking agents bound on
the matrix, which causes background ﬂuorescence and
induces experimental noise. Removal of unbound
FlAsH also eliminates the need for a BAL wash, a step
included in the initial procedure30 that reduces accuracy
(BAL affects speciﬁc binding of FlAsH to TC-tagged I
domans).
3D images of scaﬀolds on glass-bottom dish treated
with ﬂuorescently-labeled I domains were acquired by
a spectral multi-photon microscope.5 Imaging param-
eters: image planes are located 10 to 30 lm away from
the scaffold surface, 4.8 mW laser power, 775 nm laser
wavelength, 40 ls pixel acquisition time, 256 9 256
pixels, 0.21 lm pixel size, Zeiss C-apochromat
40 9 1.2 NA water immersion objective lens. For each
experiment two z-stacks are acquired per sample. After
spectral unmixing and image segmentation, ligand
density measurements are based on the FlAsH emis-
sion of pixels located at the outer surface of scaffold
struts (Supplementary Material). This emission is
converted into equivalent FlAsH concentration using a
standard curve. In contrast to the earlier preliminary
publication where ligand density was expressed in units
of ligands/lm230 here the density of ligands is
expressed in Molar units since new experimental data
showed that I domains can slowly diffuse and bind
ligands inside the whole scaffold strut volume.
Binding Model
The estimation of adhesion ligand density L0 is
based on a 1:1 binding model that describes the bind-
ing of soluble I domains to their immobilized ligands
present in the 3D matrix. In this case it can be shown
(Supplementary Material) that L0 (in units of M) can
be estimated as:
L0 ¼ 4  kD  dBss
dI0




I0¼kD
where Bss I0ð Þ is the measured concentration of I do-
mains bound on a matrix when the matrix is treated
with an I domain solution of concentration I0. The
slope dBssdI0 is estimated from binding assay data.
kD ¼ koff=kon is the dissociation constant of I domain
binding to collagen, estimated from BIACORE data.
Animal Experiments
NIH guidelines (85-23 Rev. 1985) were observed for
all surgical procedures.27 Adult female Lewis rats were
anesthetized, the sciatic nerve was anesthetized topi-
cally and transected. The nerve stumps were inserted
into the ends of a collagen conduit, leaving a 15 mm
gap between the nerve stumps. The gap is then ﬁlled
with saline, and the scaffold is secured using nylon
sutures. Animals were sacriﬁced 1 or 9 weeks post-in-
jury by CO2 inhalation. The excised tissue was ﬁxed in
4% paraformaldehyde in on ice for 8 h, immersed in
30% sucrose solution overnight, immersed in Optimal
Cutting Temperature medium, ﬂash frozen in liquid
nitrogen, cryo-sectioned at 10 lm thickness on a
microtome, and stored at 220 C. Sections were later
thawed at room temperature for 30 min, washed twice
in TBST for 10 min, blocked and permeabilized in
blocking solution (Dako) supplemented with 0.3%
Triton X100 for 1 h at room temperature, treated with
AlexaFluor488-conjugated wheat germ agglutinin
(Life Technologies) overnight at 4 C, washed twice in
PBS for 10 min, counterstained with 10 ng/ml DAPI
and 1:100 rhodamine-phalloidin (Life Technologies),
and coversliped.
Low-magniﬁcation images of labeled sections were
acquired in an Olympus IX81 ﬂuorescence microscope
equipped with an ORCA CCD detector (Hamamatsu,
Japan) using a Fluar 49 objective lens. High-magniﬁ-
cation images were acquired by a spectral multi-pho-
ton microscope.5 Imaging parameters: 8 mW laser
power, 775 nm laser wavelength, 40 ls pixel acquisi-
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tion time, 0.21 lm pixel size. The signal contributions
of emission sources was resolved by spectral unmixing.
RESULTS
The methodology developed for quantifying the
density of ligands for a particular adhesion receptor on
a 3D matrix consists of three steps: (1) Development of
soluble ﬂuorescent analogs (markers) of each adhesion
receptor of interest via genetic engineering. In contrast
to antibodies which recognize single epitopes that are
not necessarily related to adhesion ligands, such ﬂuo-
rescent analogs bind to all ligands of the corresponding
receptor with similar afﬁnity as the receptor of interest.
(2) Conduct a series of binding assays of the markers
on the 3D matrix, where the density of ﬂuorescent
markers bound on their ligands on the matrix is
quantiﬁed by 3D microscopy, and (3) Estimate the
density of adhesion ligands on the matrix by ﬁtting the
binding assay data to an appropriate binding model.
The technique is demonstrated by quantifying the
density of adhesion ligands for the two major collagen-
binding integrins (a1b1, a2b1) in two kinds of matched
porous collagen scaffolds. These biomaterials were
chosen because they recently showed remarkably dif-
ferent ability to induce regeneration in a standardized
animal model of peripheral nerve (PN) injury 9 weeks
post-injury.27 Scaffold D is similar to the FDA-ap-
proved devices IntegraTM and NeuragenTM, which are
applied clinically in patients with severe burns and
limb paralysis respectively.4,11 Scaffolds D and E have
identical pore geometry and chemical composition
(they are fabricated using the same protocol), Fig. 1a,
but differ in the ﬁnal cross-linking treatment. Scaffold
D has been cross-linked by dehydro-thermal treatment
(DHT). Scaffold E has been cross-linked chemically by
EDAC and NHS. As baseline reference, scaffold A was
the outcome of freeze-drying without cross-linking.
For each integrin of interest (a1b1, a2b1) two kinds
of soluble markers were expressed, and afﬁnity puri-
ﬁed: the non-ﬂuorescent marker (the I domain of
integrin ai subunit), and the same I domain tagged
with a tetracysteine (TC) motif. The I domain of the a
subunit of a collagen-binding integrin recognizes and
binds to the same adhesion ligand as does the cor-
responding integrin.6,16,29 When the TC tag binds the
biarsenical dye FlAsH, the complex becomes ﬂuores-
cent,1 generating soluble ﬂuorescent markers of the
ligands of the corresponding integrin. The TC-FlAsH
system was preferred over fusing I domains to a ﬂu-
orescent protein, due to its small size (1 kDa) that
was expected to affect the conformation-sensitive
binding afﬁnity of I domains much less.1 SDS-PAGE
stained by FlAsH reveals that only TC-tagged I
domains become ﬂuorescent upon FlAsH treatment
(Fig. 2a).
The properties of puriﬁed I domains were evaluated
via circular dichroism (CD) spectroscopy, and surface
plasmon resonance analysis of their binding to colla-
gen (BIACORE assay). Predictions of secondary
structure based on CD data suggest that the TC tag
slightly decreases the contribution of a-helices and b-
sheets and increases the contribution of turns and
random coil, in agreement with the published hairpin
structure of the TC tag.21 Adding the TC tag affects
acquired CD spectra hmrw kð Þ mostly below 200 nm
(Fig. 2b). CD analysis tools provide similar predictions
of secondary structure contribution (Table S1). Esti-
mated contributions for tag-free I domains agree well
with the secondary structure annotated in published X-
ray structures. Fitting BIACORE binding data
(Figs. 2c and 2d) to ﬁrst-order binding equations
suggested that the dissociation constants for a1 and a2 I
domain binding to collagen I were 8.45 lM and 9.10
lM respectively (Table S2). BIACORE data show that
binding of native non-tagged I domains (denoted as ai,
where i = 1, 2) and TC-tagged I domains (denoted as
TC-ai, i = 1, 2) to collagen have similar kinetics (TC
tag causes small kD increase) and magnitude. Finally,
both native I domains and TC-tagged I domains bind
to collagen signiﬁcantly more than gelatin (Figs. 2c
and 2d), in agreement with the known dependence of
integrin-collagen binding on collagen conforma-
tion.9,29
The density of adhesion ligands for each receptor of
interest and in each scaﬀold type was estimated based
on a series of in situ binding experiments. Samples of
collagen scaffolds were blocked and treated with
solutions of ﬂuorescent markers of increasing concen-
tration in the absence or presence of non-ﬂuorescent
markers. Binding experiments took place in the pres-
ence of either 2 mM Mg+2 (‘‘signal’’ experiments) or
10 mM EDTA (‘‘control’’ experiments). After over-
night incubation in ﬂuorescent marker solution, bio-
materials were imaged in a spectral multi-photon
microscope (Fig. 3a). The detected images contain the
emission of both collagen and FlAsH, which were
separated by spectral unmixing (Fig. 3b). Results show
that FlAsH emission in the presence of 10 mM EDTA
was always much lower compared to the emission in
the presence of 2 mM MgCl2 (Fig. 3b). The effect of
Mg+2 on TC-tagged I domain binding to its ligands on
collagen agrees with the published divalent cation-de-
pendent mechanism of integrin-ligand binding and has
been reported in previous studies of I domain binding
to collagen.6,29 Compared to the preliminary data
presented in a previous publication,30 the optimized
staining protocol utilized here resulted in 49 higher
FlAsH emission with minimal background signal
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(Fig. 3b). The density of ﬂuorescent markers that bind
speciﬁcally onto ligands on the scaffold was estimated
by subtracting the FlAsH emission of ‘‘control’’
experiments from the emission of ‘‘signal’’ experiments
(Fig. 4a). Increasing the concentration of non-ﬂuores-
cent markers in the presence of constant concentration
of ﬂuorescent markers reduced the density of ﬂuores-
cent markers bound on the scaffold, suggesting sat-
urable speciﬁc binding of I domains on the scaffold
(Fig. 4b). Adhesion ligand density was estimated by
globally ﬁtting data from a series of binding experi-
ments into a binding model that describes binding of
soluble I domains to immobilized ligands on a 3D
scaffold. Data ﬁtting provided estimates of
204.9 ± 41 lM a1b1 ligands and 248.3 ± 61 lM a2b1
ligands in scaffold D (n = 3), 29.4 ± 7.2 lM a1b1 li-
gands and 75.6 ± 11.0 lM a2b1 ligands in scaffold E
(n = 3), and 148.2 ± 26.3 lM a1b1 ligands and
214.3 ± 50.1 lM a2b1 ligands in scaffold A (n = 3)
FIGURE 2. Biochemical characterization of the purified I domains and TC-tagged I domains. (a) SDS-FlAsH-PAGE analysis of
purified fractions of non-tagged and TC-tagged I domains before and after thrombin cleavage. Samples were reduced by TCEP and
stained by FlAsH before denaturing and loading.1 After electrophoresis, the gel was imaged first in a fluorescent imager (bottom),
and then it was stained using coomasie blue and imaged in a conventional imager (top). STD: protein standards. Results highlight
that only TC-tagged I domains become fluorescent upon FlAsH treatment (b) Circular dichroism spectra of purified I domain
solutions. (c, d) Corrected sensorgrams (solid lines) and global fits (dashed lines) to a 1:1 binding model for analyte solutions of I
domains of integrin a1 (c) and integrin a2 (d). Top row: Results for solutions of non-tagged I domains. Bottom row: Results for
solutions of TC-tagged I domains. Left Column: Signal corresponding to I domain binding to a collagen surface minus the signal of
I domain binding to a blank surface. Right Column: Signal corresponding to I domain binding to a collagen surface minus the
signal of I domain binding to a gelatin surface.
cFIGURE 3. Optical-based ligand density quantification in 3D
matrices using fluorescent analogs of adhesion receptors. (a)
Schematic of the procedure for quantifying the density of
adhesion ligands on a 3D matrix (b) Representative data of the
imaging-based binding assay utilized for quantifying the
surface chemistry of a matrix in situ. 16-channel spectral data
shown after the separation of collagen and FlAsH emission by
spectral unmixing. Data display scaffold struts (detected by
the collagen autofluorescence) in the red channel and FlAsH
emission (from labeled TC-tagged I domains bound to colla-
gen ligands) in the green channel. Scaffold samples have
been treated with either 6 lM fluorescently labeled TC-a1
(rows 1, 2) or 6 lM TC-a2 (rows 3–4) in the presence of 2 mM
MgCl2 (‘‘signal’’ experiments, rows 1 and 3) or 10 mM EDTA
(‘‘control’’ experiments, rows 2 and 4). Bar: 20 lm.
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(Fig. 4c). These data showed that EDAC-NHS cross-
linking reacts with and effectively destroys a1b1, a2b1
ligands in scaffold E, in agreement with the known
chemical mechanism of EDAC (attacks carboxyl
groups), and the presence of carboxyl groups in key
acidic residues of a1b1, a2b1 ligands.
24 On the other
hand, DHT cross-linking appeared not to affect the
surface chemistry of the scaffolds since the measured
ligand density of scaffolds D and A were not signiﬁ-
cantly different.
The importance of the surface chemistry of a 3D
matrix is demonstrated by quantifying its eﬀects in the
application of collagen scaﬀolds in PN regeneration. It
has been shown that certain porous collagen scaﬀolds
can induce regeneration in skin and PN, and that this
regenerative ability depends strongly on speciﬁc scaf-
fold features.27,34 The underlying molecular details of
this dependence are not known yet. Experimental data
from skin34 and PN regeneration27 and recent obser-
vations in African mice that spontaneously regenerate
FIGURE 4. Quantifying the surface chemistry of porous collagen scaffolds in situ. (a) Equivalent concentration of fluorescent I
domains bound on scaffold D as a function of fluorescent marker concentration and the presence of Mg+2. (b) Competitive binding
of 1.5 lM fluorescent I domains on scaffold D in the presence of increasing concentrations of non-fluorescent I domains. (c)
Estimated concentrations of ligands of integrin a1b1 (left), and a2b1 (right) in scaffolds D, E and the baseline scaffold A demonstrate
that scaffold D contains significantly more ligands of a1b1 and a2b1 than scaffold E. A pairwise t test suggests that the density of
a1b1 or a2b1 ligands in scaffolds D and E are significantly different (p 5 0.047 and p 5 0.101, n 5 3, respectively). A pairwise t test
suggests that the density of a1b1 or a2b1 ligands in scaffolds D and A are not significantly different (p 5 0.319 and p 5 0.690, n 5 3,
respectively).
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FIGURE 5. Tubular collagen scaffolds of different surface chemistry grafted in transected peripheral nerves interact differently
with contractile cells that cause wound contraction. (a) Schematic of the rat sciatic nerve transection model. (b) Schematic of the
morphology observed in cross-sections of harvested nerves from animal groups D (left) or E (right) 9 weeks post-injury. A capsule
of contractile cells (C; red) forms between newly-formed nerve tissue (N; blue) and scaffold (S; green). In group E a large void
volume (V) forms between the capsule and the scaffold’s inner lumen. (c) Fluorescent images of nerve cross sections, harvested 1
(top row) or 9 weeks post injury (bottom row). Sections were stained for actin (phalloidin; red), cell content (Wheat Germ
Agglutinin; green) and nuclei (DAPI; blue). Nerve trunks are highlighted by a white dashed line. Bars: 200 lm.
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their skin26 suggest that regenerative activity correlates
with down-regulation of wound contraction. The
requirement for cells to adhere to their surrounding
matrix in order to apply signiﬁcant contractile forces
suggests that the surface chemistry of a biomaterial
may affect its regenerative activity via regulating
wound contraction. In order to get evidence that could
support this hypothesis, a follow-up study of the pre-
vious 9-week animal study,27 was designed: rat sciatic
nerves were transected, the resulting stumps were
separated by 15 mm, inserted in tubular collagen
scaffolds D or E (Fig. 5a) and harvested 1 or 9 weeks
post-injury. The 9 week time point serves as an indi-
cator of the ﬁnal wound healing outcome.7 The 1 week
time point provides evidence about the effects of the
biomaterial during the critical early wound healing
response.32
Low magniﬁcation images of PN regenerates har-
vested 1 or 9 weeks post-injury (Figs. 5b and 5c) show
an assembly of contractile cells (capsule) that sur-
rounds the newly formed nerve tissue (regenerate). The
mechanical forces applied by capsule cells are the ori-
gin of macroscopic wound contraction.33 The diameter
and number of axons that manage to cross half the gap
9 weeks post-injury have been proposed as quality
metrics of the wound healing outcome. The nerve
regenerate in animal group D had a signiﬁcantly larger
diameter compared to animal group E both 1 and
9 weeks post-injury, in agreement with its increased
regenerative activity.27 Furthermore, regenerates in
animal group D were surrounded by a signiﬁcantly
thinner capsule compared to group E (82.9 ± 8.6 lm
vs. 158.0 ± 31.3 lm 1 week post-injury, 31 ± 5 lm vs.
73 ± 18 lm 9 weeks post-injury, n = 3), a sign of re-
duced wound contraction (Figs. 5b and 5c). In both
animal groups, the contractile cell capsule (highlighted
as ‘‘C’’) has already ﬁlled the volume between the
regenerate and the scaffold as soon as 1 week post-
injury, suggesting fast kinetics of wound contraction
that could potentially have signiﬁcant effects in the
delicate ﬁbrin bridge that connects the two nerve
stumps during the early phase of wound healing.32
Low magniﬁcation images suggest two possible
ways that scaﬀold surface-chemistry that could aﬀect
the wound healing outcome. First, they show that
capsule cells have diﬀerent extent of contact with the
surrounding scaﬀold. In group D capsule cells make
ﬁrm contact with the surrounding scaﬀold both at 1
and 9 weeks post-injury around the whole perimeter of
the regenerate (Figs. 5b and 5c left). On the other
hand, during cryo-sectioning of samples from animal
group E there were frequent artifacts (tears) in the
capsule-scaffold interface, in agreement with the
hypothesis that capsule cells are not strongly attached
to the surrounding scaffold E. 9 weeks post-injury in
animal group E the capsule and the scaffold are usually
separated by void volume suggesting loss of contact or
poor cell-scaffold adhesion (Figs. 5b and 5c right).
Second, the extent of cell migration inside the two
kinds of scaffolds is very different. In group D a sig-
niﬁcantly larger number of cells inﬁltrates inside the
scaffold both at 1 and 9 weeks post-injury compared to
group E (Fig. 5c), suggesting that cells cannot migrate
inside scaffold E despite the fact that is made of col-
lagen I.
High-magniﬁcation multi-photon imaging was then
utilized to zoom in the same cross sections and study in
detail the region where capsule cells bind to the colla-
gen scaﬀold. High magniﬁcation images show that the
capsule consists of circumferentially-oriented collagen
ﬁbers (visualized via the second harmonic emission of
tissue collagen) and actin-rich contractile cells (Fig. 6).
The different extent of cell-scaffold interactions is
again evident. In group D contractile cells in the outer
layer of the capsule bound extensively on the scaffold
inner lumen and their long axis intersected with the
scaffold outline, indicating that cells transmit forces to
the scaffold (Fig. 6 left). By contrast, in group E cap-
sule cells in the outer capsule layer stain strongly for
actin, were much more elongated (both signs of
increased contractility), and their long axes were
strongly aligned in the circumferential direction. These
observations suggest that in animal group E capsule
cells apply forces to each other rather than to the
surrounding scaffold. The strictly circumferential ori-
entation and high cell aspect ratio is observed in ani-
mal group E both at 1 and 9 weeks post-injury and is
independent on whether the capsule is in contact with
the surrounding inner lumen of the scaffold (Fig. 6
right).
High resolution imaging also reveals that in group
D, many individual cells managed to migrate inside the
scaﬀold (as soon as 1 week post-injury) and bind to its
struts in a spindle-like shape. These cells are contractile
(stain brightly for actin) and synthesize new collagen
ﬁbers, which are detected based on their bright second
harmonic emission (Fig. 6 bottom left). On the other
hand, in animal group E the scaffold area in the
proximity of its inner lumen lacks any inﬁltrating cells
(Fig. 6 bottom right).
DISCUSSION
This work presents a novel technique for quantify-
ing the surface chemistry of an insoluble 3D matrix,
such as tissue ECM or a biomaterial. The technique
fulﬁlls the critical need to quantify and compare the
chemical stimuli provided to cells by various insoluble
microenvironments. It provides a direct description of
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the chemical microenvironment perceived by cells, in
contrast to measurements of average macroscopic
properties (e.g. chemical composition) that are not
entities directly sensed by cells.
While several studies have focused on the molecular
interactions between cell adhesion receptors and ECM
molecules in vitro,6,29 it has not been so far possible to
quantify the extent of these interactions in the native 3D
insoluble microenvironment where cells actually interact
with these molecules. It is expected that the magnitude of
chemical stimuli provided by amatrix to cells depends on
its chemical composition, component cross-linking,
chemical treatments, nanoscale topology and spatial
arrangement of matrix molecules in 3D space.18,22,28
Here, the technique utilizes TC-tagged I domains as
ﬂuorescent analogs of collagen-binding integrins. I
domains have been extensively utilized to study inte-
grin binding to collagens.6,21,29 Although most studies
focus on I domain binding to tropocollagen, collagen I
in tissues always forms super-molecular structures such
as ﬁbrils and ﬁbers. A related study revealed that ﬁbril
formation reduced the afﬁnity of I domains to colla-
gen.17 This study goes a step further, and utilizes ﬂu-
orescent I domains to quantify in situ for the ﬁrst time
the surface chemistry of two matched scaffolds made
of microﬁbrillar collagen I (the ﬁbril nature of collagen
causes the D-banding shown in Fig. 1c).
Biochemical characterization of puriﬁed I domains
overall suggest that the addition of the TC tag makes I
domains ﬂuorescentwithout signiﬁcantly disturbing their
secondary structure and binding characteristics to colla-
gen (Fig. 2, Tables S1, S2). Data show that a2 was af-
fectedmore by the addition of theTC tag compared to a1.
Optimized FlAsH staining of TC-tagged I domains im-
proved signiﬁcantly the sensitivity and accuracy of the
method compared to the preliminary procedure30 and
provided the sensitivity required to discriminate 3D
matrices of different surface chemistry.Results show that
scaffold D (cross-linked by DHT) provides to cells
204.9 ± 41 lM a1b1 and 248.3 ± 61 lM a2b1 ligands.
This is approximately one order of magnitude higher
compared to the density of ligands providedby scaffoldE
(cross-linked by EDC and NHS) and not signiﬁcantly
different compared to the density of ligands provided by
the uncross-linked scaffold. These results highlight a
signiﬁcant effect of the cross-linking method on bioma-
terial surface chemistry.
Although the results presented focus on ligands of
integrins a1b1, a2b1 on porous collagen scaffolds, the
methodology can be extended to quantify the ligands
for different types of adhesion receptors in different
kinds of cell-free matrices such as biomaterials, phys-
iologic vs. pathologic tissue ECM, or decellularized
tissues. Prerequisites for such extensions are the
development of appropriate ﬂuorescent analogs of the
adhesion receptor of interest, and the utilization of an
appropriate binding model that can describe the nature
of marker binding on the matrix under investigation.
FIGURE 6. High-magnification multi-photon images of ex vivo nerve cross sections highlight differences in the cell binding
pattern to collagen scaffolds of different surface chemistry. All images are zoom-ins of the fluorescent images shown in Fig. 5,
acquired in the bottom right corner of nerve tissue. Nerve cross sections were grafted with scaffolds D (left column) or E (right
column) and harvested 1 week (top row) or 9 weeks (bottom row) post injury. Images are shown after spectral unmixing displaying
the key sources of emission in the samples: WGA (yellow), phalloidin (purple), DAPI (blue), collagen autofluorescence (green) and
second harmonic emission (red). Bars: 50 lm.
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Ligand density measurements can help clarify how
3D matrices modulate key cell phenotypes that aﬀect
biological processes. First, the signiﬁcantly more
extensive cell adhesion (adhesion of capsule cells to the
scaﬀold inner lumen, adhesion of cells to scaﬀold struts
as they migrate inside the scaﬀold) to scaﬀold D
compared to scaﬀold E (Figs. 5, 6) could result by the
increased ligand density of scaffold D (Fig. 4). This
dramatic effect in cell-scaffold adhesion cannot be
explained by differences in other material properties,
speciﬁcally the sevenfold increased stiffness,13 and the
increased in vivo degradation rate of scaffold E com-
pared to scaffold D.14 In addition, the contractile cell
capsule morphology observed 9-weeks post-injury in
animal group E resembles the one observed in tran-
sected PN grafted with silicone tubes,8 materials that
lack adhesion ligands, suggesting that this similarity
can be explained by a paucity of adhesion ligands in
scaffold E. We speculate that the limited ability of cells
to bind scaffold E could lead cells to instead interact
more with their surrounding cells and could possibly
explain why in animal group E a thicker capsule con-
sisting of multiple concentric layers of contractile cells
forms within 1 week.
The combined observations of Figs. 4, 5, and 6 also
agree with a simple mechanism that has been proposed
to partly explain how biomaterials regulate the wound
healing outcome.33 This mechanism suggests that
regeneration is impeded by the effects of mechanical
stress ﬁelds in the wound, induced by cell forces in the
contractile cell capsule. In the case of PN, elementary
cell forces in the capsule sum up along the circumfer-
ential axis (hoop stresses) causing compression of the
enclosed nerve tissue, which was shown to correlate
inversely with the quality of the wound healing out-
come.27
Finally, the new technique oﬀers a way for bringing
materials science closer to quantitative biology. So far,
any chemical stimuli provided by the surrounding
matrix to cells have been described in a qualitative
manner. By providing a standardized quantiﬁcation of
the chemical stimuli provided by a matrix to cells, the
new method enables the incorporation of matrix eﬀects
in quantitative systems-level models of signal trans-
duction. Eﬀorts in this area have so far neglected to
account for signal transduction eﬀects of the sur-
rounding matrix.
ELECTRONIC SUPPLEMENTARY MATERIAL
The online version of this article (doi:
10.1007/s10439-015-1445-x) contains supplementary
material, which is available to authorized users.
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